Pfreundschuh, M., & Witzens-Harig, M. (2014). Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II): Extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group. Journal of clinical oncology, 32, . doi:10.1200/JCO.2013.54.6861

"Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II) : Extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group / Pfreundschuh M., Poeschel V., Zeynalova S., Hänel M., Held G., Schmitz N., Viardot A., Dreyling M.H., Hallek M., Mueller C., Wiesen M.H., Witzens-Harig M., Truemper L., Keller U., Rixecker T., Zwick C., Murawski N" Journal of Clinical Oncology .

Pfreundschuh, Michael, and Mathias Witzens-Harig. "Optimization of Rituximab for the Treatment of Diffuse Large B-Cell Lymphoma (II): Extended Rituximab Exposure Time in the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group." Journal of Clinical Oncology 32 (2014).